Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone + ascorbic acid + Neurobion in multiple trauma patients
IRCT20201116049410N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrocortisone, ascorbic acid and Neurovit Forte in polytrauma, sponsored by Isfahan University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
hydrocortisoneascorbic acidNeurovit Forte
03
Conditions
polytrauma
Beyond the preview
Go deeper on IRCT20201116049410N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201116049410N1.